Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico

Published:2014-10-03 Issue:10 Volume:10 Page:2853-2863
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Dayan Gustavo H¹,Galán-Herrera Juan-Francisco²,Forrat Remi³,Zambrano Betzana⁴,Bouckenooghe Alain⁵,Harenberg Anke³,Guy Bruno³,Lang Jean³

Affiliation:

1. Research and Development Department; Sanofi Pasteur; Swiftwater, PA USA

2. CIFBiotec, Mexico DF, Mexico

3. Research and Development Department; Sanofi Pasteur; Lyon, France

4. Research and Development Department; Sanofi Pasteur; Montevideo, Uruguay

5. Research and Development Department; Sanofi Pasteur; Singapore

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/21645515.2014.972131

Reference26 articles.

1. The global distribution and burden of dengue

2. The History of Dengue Outbreaks in the Americas

4. Dengue hemorrhagic fever with special emphasis on immunopathogenesis

5. Review of dengue virus and the development of a vaccine

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A stochastic B cell affinity maturation model to characterize mechanisms of protection for tetravalent dengue vaccine constructs;Frontiers in Molecular Biosciences;2023-07-14

2. The recent outbreak of dengue in Bangladesh is a public and global threat to the international communities; what should we do to mitigate it?;International Journal of Surgery: Global Health;2023-06-08

3. Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model;Pathogens;2022-02-25

4. Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines;Frontiers in Immunology;2021-08-20

5. Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial;Human Vaccines & Immunotherapeutics;2021-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3